Global Insulin Delivery Devices Market (2018-2025)-GMI Research Global Insulin Delivery Devices Market (2018-2025) | Page 3

Source: GMI Research
Asia-Pacific is expected to hold the largest share in the market,
followed by North America owing to the reimbursement facilities and
presence of large number of companies that are investing in research
and development to expand their product portfolio. Favourable
government policies, improvement in the healthcare infrastructure,
and private funding in emerging economies of Asia-Pacific and LAMEA
are expected to boost the market growth in the coming years.
Various notable players operating in global insulin delivery devices
market include Abbott Laboratories, Ypsomad Holding AG, F.
Hoffmann-La Roche Ltd, Terumo Corporation, Insulet Corporation,
Medtronic, Animas Corporation, Becton, Dickinson and Company,
Dexcom, Inc., Sanofi, and others.
The global insulin delivery devices market has been segmented on the
basis of product type, end user and key geographies. Based on product
type, the market comprises of insulin syringes, insulin pens, insulin
pumps and insulin jet injectors. The end user segment includes, home
care setting, hospitals and others. This research report “global insulin